3-(4-bromo-2-fluorophenyl)-4,5-dihydro-1,2-oxazole-5-carboxylic acid, 95.0%, 2g

8-Acetyl-6-(benzyloxy)-2H-benzo[b][1,4]oxazin-3(4H)-one, 95.0%, 250mg

5-bromo-1-methyl-3-(trifluoromethyl)-1H-1,2,4-triazole, 95.0%, 1g

2-Methyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)isoquinolin-1(2H)-one, 98%, 5g

1-(4-Bromophenyl)-3,5-dimethyl-1H-pyrazole, 95.0%, 1g

5-Amino-3-methylbenzo[d]isoxazole, 95.0%, 1g

Bis(2-ethylhexanoato)hydroxyaluminum>98.0%(T)25g

(S)-4-TERT-BUTYL-2-(2-PYRIDYL)OXAZOLINE, 98%, 10g

6-METHYL-5-NITRONICOTINIC ACID, 95.0%, 5g

Báscula analítica y de precisión serie Entris® II Modelos con ajuste interno, no certificada, 0,01 g, 2200 g, BCE2202i-1S

Tert-butyl(4s)-4-[(E)-3-bromoprop-1-enyl]-2,2-dimethyl-oxazolidine-3-carboxylate, 97% mix TBC as stabilizer, 100mg

2-(4-Fluoro-3-methylphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95.0%, 10g

4-Chloro-1-methylquinolin-2(1H)-one, 97%, 500mg